Sky Covione's COVID-19 vaccine production has been halted by SK Bioscience.

SK Bioscience said on Wednesday that due to its low vaccination rate, finished products of Koreas first COVID-19 vaccine Sky Covione arent being manufactured . SK Bioscience said on Wednesday that due to its low vaccination rate, finished products of Koreas first COVID-19 vaccine Sky Covione arent being manufactured .

SK Bioscience said on Wednesday that due to its low vaccination rate, finished products of Koreas first COVID-19 vaccine Sky Covione aren't being manufactured.According to a SK Bioscience spokeswoman, the company obtained item approval on June 29 and started selling vaccines on September, but that production was suspended due to low demand.Due to a low vaccination rate, Sky Covione is currently not being offered, and we will resume production as soon as the government wants it.We are still waiting for international clearances for overseas sales, according to reports from the Korea Centers for Disease Control and Prevention, for the Sky Covione vaccine, only 493 people were administered it from the 1st to the 20th of this month.

The number of people who took the Sky Covione vaccine is significantly lower than the Pfizer vaccine, according to SK Bioscience.In July, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) accepted a conditional marketing authorization (CMA).In early September, the World Health Organization (WHO) accepted an emergency use order (EUA) to facilitate prompt delivery of vaccines and treatments.Sadly, nothing has been published yet.

.
.
.
.